Stroke biomarkers – the search for a rapid predictive test
This article was originally published in Clinica
Executive Summary
Stroke is the third leading cause of death in the US, and its cost to the country's healthcare system totalled $68.9bn in 2009, according to the American Heart Association. Timely and accurate diagnosis of stroke is critical to improving treatment. In this article, Phil Greenfield reports on the progress made in stroke biomarker research and the development of a truly predictive, rapid blood test
You may also be interested in...
Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment
In this edition of Report Digest, UK-based reporter Barnaby Pickering talks about the prostate cancer diagnostics and minimally invasive treatments markets with analyst Phil Greenfield. The two discuss ongoing developments in both treatment and diagnosis, while exploring driving and limiting factors for both.
Using Digital Tools To Unpick The Adherence Problem
An ambitious five-year public-private partnership plans to tackle non-adherence to medicines by giving patients EU-wide access to regulator-approved digital drug information. One year in, progress has been made in creating an app that could do just this.
In A First, FDA Approves Radioembolization Treatment For Liver Cancer In US
Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.